During December 2021, the United States experienced a surge in COVID-19 cases, coinciding with predominance of the SARS-CoV-2 B.1.1.529 (Omicron) variant (1). During this surge, the National Football League (NFL) and NFL Players Association (NFLPA) adjusted their protocols for test-to-release from COVID-19 isolation on December 16, 2021, based on analytic assessments of their 2021 test-to-release data. Fully vaccinated* persons with COVID-19 were permitted to return to work once they were asymptomatic or fever-free and experiencing improving symptoms for ≥24 hours, and after two negative or high cycle-threshold (Ct) results (Ct≥35) from either of two reverse transcription-polymerase chain reaction (RT-PCR) tests† (2). This report describes data from NFL's SARS-CoV-2 testing program (3) and time to first negative or Ct≥35 result based on serial COVID-19 patient testing during isolation. Among this occupational cohort of 173 fully vaccinated adults with confirmed COVID-19 during December 14-19, 2021, a period of Omicron variant predominance, 46% received negative test results or had a subsequent RT-PCR test result with a Ct≥35 by day 6 postdiagnosis (i.e., concluding 5 days of isolation) and 84% before day 10. The proportion of persons with positive test results decreased with time, with approximately one half receiving positive RT-PCR test results after postdiagnosis day 5. Although this test result does not necessarily mean these persons are infectious (RT-PCR tests might continue to return positive results long after an initial positive result) (4), these findings indicate that persons with COVID-19 should continue taking precautions, including correct and consistent mask use, for a full 10 days after symptom onset or initial positive test result if they are asymptomatic.
[1]
D. Anderson,et al.
Optimizing SARS-CoV-2 Surveillance in the United States: Insights From the National Football League Occupational Health Program
,
2021,
Annals of Internal Medicine.
[2]
Nuno R. Faria,et al.
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
,
2021,
PLoS biology.
[3]
D. Ho,et al.
SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.
,
2021,
JAMA internal medicine.
[4]
C. Heneghan,et al.
Viral cultures for COVID-19 infectious potential assessment – a systematic review
,
2020,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5]
J. I. Hoffman.
Proportions
,
2019,
Basic Biostatistics for Medical and Biomedical Practitioners.